From gene discovery, to database, to cancer treatment. COSMIC celebrates 15 years of fuelling cancer research. New article featuring COSMIC on the Sanger Institute blog. By Ali Cranage, Science Writer at the Wellcome Sanger Institute.
We are excited to announce the DFCI/BCH/BWH COSMIC Workshop on September 20, 2019! This workshop, in conjunction with Dana-Farber Cancer Institute (DFCI), is designed to bring together the clinicians and researchers at DFCI, Boston Children's Hospital (BCH) and Brigham and Women's Hospital (BWH), with members of the COSMIC Team to review the valuable COSMIC resource.
Europe PMC, an archive of life sciences journal literature, has added links to COSMIC enabling easier access to cancer mutation data.
COSMIC v89 (May 2019) has just been released! In this release we have 4 newly expert-curated genes: DDX3X, LATS1, PIK3CB and NCOR2; and a significant update to bile duct cancer (cholangiocarcinoma).
As part of release v89 we have focused on updating the expert-curated mutation data for bile duct cancer (cholangiocarcinoma). Approximately 60 additional publications that include mutation screening data in this disease are included in the release.
We are pleased to announce a major expansion of the mutational signatures, based on the analysis of 84,729,690 somatic mutations from 4,645 whole cancer genome and 19,184 exome sequences encompassing most cancer types.
The COSMIC v88 release is now live! We have 4 newly expert-curated genes: PTPRT, MAP3K1, LEF1 and LATS2; and a significant update to TSC1 and TSC2.
As part of release v88 we have focused on updating the expert-curated mutation data for TSC1 and TSC2 genes. This includes approximately 60 additional publications that include mutation screening data for these genes.
COSMIC will be presenting at the American Association of Cancer Research (AACR) Annual Meeting 2019 later this month.